These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 10917466

  • 41. Eosinophil cationic protein (ECP) in saliva: a new marker of disease activity in bronchial asthma.
    Schmekel B, Ahlner J, Malmström M, Venge P.
    Respir Med; 2001 Aug; 95(8):670-5. PubMed ID: 11530956
    [Abstract] [Full Text] [Related]

  • 42. Eosinophilic cationic protein as a marker of nasal inflammation in patients with cystic fibrosis.
    Weber A, Kiefer J, Peters S, Schneider M, Bargon J, May A.
    Laryngoscope; 1999 Oct; 109(10):1696-702. PubMed ID: 10522945
    [Abstract] [Full Text] [Related]

  • 43. Sputum eosinophilia in Churg-Strauss syndrome.
    Meziane H, Maakel ML, Vachier I, Bousquet J, Chanez P.
    Respir Med; 2001 Oct; 95(10):799-801. PubMed ID: 11601744
    [Abstract] [Full Text] [Related]

  • 44. Eosinophil activation in the lung is related to lung damage in adult respiratory distress syndrome.
    Hällgren R, Samuelsson T, Venge P, Modig J.
    Am Rev Respir Dis; 1987 Mar; 135(3):639-42. PubMed ID: 3030169
    [Abstract] [Full Text] [Related]

  • 45. Health effects of acute exposure to air pollution. Part I: Healthy and asthmatic subjects exposed to diesel exhaust.
    Holgate ST, Sandström T, Frew AJ, Stenfors N, Nördenhall C, Salvi S, Blomberg A, Helleday R, Söderberg M.
    Res Rep Health Eff Inst; 2003 Dec; (112):1-30; discussion 51-67. PubMed ID: 14738208
    [Abstract] [Full Text] [Related]

  • 46. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy.
    Sigurs N, Bjarnason R, Sigurbergsson F.
    Acta Paediatr; 1994 Nov; 83(11):1151-5. PubMed ID: 7841728
    [Abstract] [Full Text] [Related]

  • 47. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbations.
    Wever AM, Wever-Hess J, Hensgens HE, Hermans J.
    Respir Med; 1994 Sep; 88(8):613-21. PubMed ID: 7991887
    [Abstract] [Full Text] [Related]

  • 48. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function.
    Hällgren R, Bjermer L, Lundgren R, Venge P.
    Am Rev Respir Dis; 1989 Feb; 139(2):373-7. PubMed ID: 2536526
    [Abstract] [Full Text] [Related]

  • 49. Comparison of sputum-ECP levels in bronchial asthma and chronic bronchitis.
    Virchow JC, Kroegel C, Hage U, Kortsik C, Matthys H, Werner P.
    Allergy; 1993 Feb; 48(17 Suppl):112-8; discussion 143-5. PubMed ID: 8109700
    [Abstract] [Full Text] [Related]

  • 50. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis.
    Koller DY, Urbanek R, Götz M.
    Am J Respir Crit Care Med; 1995 Aug; 152(2):629-33. PubMed ID: 7633718
    [Abstract] [Full Text] [Related]

  • 51. Serum eosinophil cationic protein levels measured during exacerbation of asthma: characteristics of patients with low titres.
    Matsumoto H, Niimi A, Minakuchi M, Izumi T.
    Clin Exp Allergy; 2001 Apr; 31(4):637-43. PubMed ID: 11359433
    [Abstract] [Full Text] [Related]

  • 52. Airway inflammation in COPD assessed by sputum levels of interleukin-8.
    Yamamoto C, Yoneda T, Yoshikawa M, Fu A, Tokuyama T, Tsukaguchi K, Narita N.
    Chest; 1997 Aug; 112(2):505-10. PubMed ID: 9266891
    [Abstract] [Full Text] [Related]

  • 53. Markers of airway inflammation in preschool wheezers.
    Carlsen KH.
    Monaldi Arch Chest Dis; 1997 Oct; 52(5):455-60. PubMed ID: 9510666
    [Abstract] [Full Text] [Related]

  • 54. Eosinophil activity in bronchial asthma.
    Venge P.
    Allergy Proc; 1994 Oct; 15(3):139-41. PubMed ID: 7926713
    [Abstract] [Full Text] [Related]

  • 55. Comparison of sputum and serum eosinophil cationic protein (ECP) levels in nonatopic asthma and chronic obstructive pulmonary disease.
    Gürsel G, Türktas H, Gökçora N, Tekin IO.
    J Asthma; 1997 Oct; 34(4):313-9. PubMed ID: 9250255
    [Abstract] [Full Text] [Related]

  • 56. Inflammation markers and symptom activity in children with bronchial asthma. Influence of atopy and eczema.
    Carlsen KH, Halvorsen R, Pettersen M, Carlsen KC.
    Pediatr Allergy Immunol; 1997 Aug; 8(3):112-20. PubMed ID: 9532250
    [Abstract] [Full Text] [Related]

  • 57. Serum inflammatory markers and effects of age and tobacco smoke exposure in young non-asthmatic children.
    Lødrup Carlsen KC, Halvorsen R, Carlsen KH.
    Acta Paediatr; 1998 May; 87(5):559-64. PubMed ID: 9641740
    [Abstract] [Full Text] [Related]

  • 58. [Analysis of circumstances of the development of chronic bronchitis in patients treated at Bydgoszcz Lung Disease Clinic in 1993-1996].
    Słowik-Gabryelska A.
    Pol Merkur Lekarski; 1998 Dec; 5(30):321-4. PubMed ID: 10101513
    [Abstract] [Full Text] [Related]

  • 59. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease.
    Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, Donner CF.
    Eur Respir J; 1998 Aug; 12(2):380-6. PubMed ID: 9727789
    [Abstract] [Full Text] [Related]

  • 60. Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease.
    Dahlén I, Janson C, Björnsson E, Stålenheim G, Peterson CG, Venge P.
    Respir Med; 2001 Nov; 95(11):891-7. PubMed ID: 11716203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.